Executive Editor
- Dafne Solera, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Pharmacology 2011, 11:10PAR2 protects against vascular dysfunction
Vasodilatation mediated by protease-activated receptor 2 (PAR2) is retained in a mouse model of Angiotensin-II induced hypertension and mesenteric arterial vascular dysfunction, through a mechanism dependent on the calcium-activated potassium channel SK3.1.
Hot topic
BMC Pharmacology 2011, 11(Suppl 1):P61 (1 August 2011)
Scope
BMC Pharmacology is an open access, peer-reviewed journal that considers articles on aspects of the discovery, design, uses, effects, modes of action and metabolism of chemically defined therapeutic and toxic agents.
From the blog
- 30 January 2012
- BMC-series journals on track for Impact Factor
- 18 January 2012
- Bacterial symbionts – the key to fighting pests and diseases?
- 10 January 2012
- BMC Ecology starts 2012 on a high!
Latest supplements
Volume 11 Suppl 2 (5 September 2011)
17th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Meeting abstracts
Innsbruck, Austria. 29-30 September 2011
Quote
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."
Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA
Email alerts
Receive periodic news and updates relating to BioMed Central.
RSS
Comments
View more comments